Want to join the conversation?
$A said its Diagnostic and Genomics Group (DGG) delivered 5% core growth in 2Q16 against a difficult compare. The pathology business continues on its steady trajectory back to market growth rates, highlighted by a strong demand for a new PD-L1 companion and complementary diagnostics test. DGG's operating margin was flat versus a year ago at 15%.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!